MIND diet tested for MS: a Brain-Healthy eating plan to fight fatigue and fog

NCT ID NCT07057999

Completed Symptom relief Sponsor: Betul Uner Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether the MIND diet—a mix of Mediterranean and DASH diets—could improve fatigue, quality of life, and brain fog in 62 adults with multiple sclerosis. Participants followed either the MIND diet or a traditional healthy diet for 3 months, with weekly online check-ins. Researchers measured changes using questionnaires and blood tests to see if this eating plan offers extra benefits for MS symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MIND diet (a combination of Mediterranean and DASH diets)
What this could lead to: If it works, this could offer a simple dietary approach to help manage fatigue and brain fog in people with multiple sclerosis.
What could go wrong: This is a small, completed trial with 62 participants, so results may not apply to everyone. Dietary changes can be hard to maintain, and any benefits might be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BODY COMPOSITION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Mental Fatigue multiple sclerosis myalgic encephalomeyelitis/chronic fatigue syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BODY COMPOSITION BRAIN FOG DIET THERAPY FATIGUE SYNDROME, CHRONIC MULTIPLE SCLEROSIS QUALITY OF LIFE (QOL) RANDOMISED CONTROLLED TRIAL

Contacts and locations

Locations

Muğla Sıtkı Koçman University/Muğla Training and Research Hospital Neurology Polyclinic

Muğla, Mentese, 48000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.